Issue 26
Get instant access to latest e-book

latest newsRead more...

29

Apr 2017

Allergan Successfully Completes ZELTIQ® Aesthetics Acquisition

Allergan plc a leading global biopharmaceutical company today announced it has successfully completed the acquisition of ZELTIQ Aesthetics Inc a medical technology company behind a proprietary controlledcooling fat reducing treatment CoolSculpting Allergan acquired ZELTIQ Aesthetics for approximately billion in cash ZELTIQ stockholders approved the transaction…

29

Apr 2017

Takeda Announces FDA Accelerated Approval of ALUNBRIGTM (brigatinib)

Takeda Pharmaceutical Company Limited announced that ALUNBRIG brigatinib has received Accelerated Approval from the US Food and Drug Administration FDA for the treatment of patients with anaplastic lymphoma kinasepositive ALK metastatic nonsmall cell lung cancer NSCLC who have progressed on or are intolerant to crizotinib…

28

Apr 2017

BridgeBio Pharma Launches Eidos Therapeutics to Develop Targeted Therapy for Fatal Heart Disease

BridgeBio Pharma announced the launch of Eidos Therapeutics a biopharmaceutical company developing a novel smallmolecule treatment for transthyretin TTR amyloidosis BridgeBio has committed million and seasoned RD executives to advance Eidos lead compound AG TTR amyloidosis is a progressive fatal disease without an FDAapproved therapy…

press releasesRead more...

29

Apr 2017

Lonza to Host Webinar:

Lonza is hosting a free minute webinar on May emphasizing the importance of data integrity for endotoxin testing With data integrity being a critical area for the endotoxintesting community Robert…

29

Apr 2017

Aeterna Zentaris to Announce Top-Line Results of the ZoptEC Phase 3 Clinical Study of Zoptrex™

Aeterna Zentaris Inc will announce the topline results of the ZoptEC Phase clinical study of Zoptrex zoptarelin doxorubicin in women with locally advanced recurrent or metastatic endometrial cancer prior to…

28

Apr 2017

Sunil Gutte Becomes an Active Participant in CSR Activities of Sunil Hitech Engineers Ltd.

Business Wire IndiaSunil HiTech Engineers Ltd conceptualizes Corporate Social Responsibility CSR as its core value of their corporate citizenship and good governance Mr Sunil Gutte the Managing Director of the…

EventsRead more...

29-30

Apr 2017

4th Asia-Pacific Gastroenterology Cancer Summit (APGCS)

MCI Middle East
Grand Hyatt, Singapore

01-04

May 2017

Pharmaceutical Regulations Summit

Informa Middle East
The Address Dubai Marina

TOP ARTICLES

  • 3

    Parenteral Preparations

    INTRODUCTION Parenteral preparations are defined as solutions suspensionsemulsions for injection or infusion powders for injection or infusion gels for injecti..

Knowledge Bank

  • Interviews

    Datwyler Pharma Packaging

    Senior Manager Global Scientific Affairs
    Renaud Janssen PhD is the Senior Manager of Global Scientific Affairs at Datwyler Pharma Packaging He frequently presents on international conferences on subjects related to elastomeric and aluminiumplastic closures for pharmaceutical applications Re..

  • Articles

    Nanotechnology-based Inhalation Treatment for Lung Cancer

    The lungs are the primary organ of the respiratory system The respiratory system works with the circulatory system to deliver oxygen from the lungs to the cells and remove carbon dioxide and return it to the lungs to be exhaled Respiration means exchange of oxygen and carbon dioxide between the air blood and body…

  • Techno Trends

    Anticancer Drugs Breakthrough to Revolutionize New Medications

    A breakthrough has been discovered by an international group of computer scientists Researchers have developed a Generative Adversarial Autoencoders AAE for generating novel molecular finger prints with a defined set of parameters A layer AAE architecture with the latent middle layer serving as a discriminator was developed As an input and output the AAE uses a vector of binary fingerprints…

Editorial Section

  • Strategy

    Generics in Switzerland

    The article talks about the Swiss Generics market the penetration rate of generics in Switzerland why generics are a safe and smarter choice manufactured to modern standards with affordable prices and the threat of government forcing generic companies to benchmark…

  • Research development

    Biologics and Biosimilars

    With the early generation of biologics starting to lose patent protection the field of biosimilars too has been gaining attention Biosimilars are the generic version of a biologic drug developed for launch post the patent expiry of the original drug…

  • Clinical Trails

    Patient Recruitment

    To address the challenges faced in patient recruitment and retention in clinical trials innovative technologies are being utilised in AsiaPacific as well as other regions to optimise the processes involved From patient matching to improving the consent process technology has…

  • Expert Talk

    Biologics’ Drug Delivery Systems

    In this interview Peter Soelkner of Vetter discusses drug delivery trends for biologics and in particular prefilled syringes He offers insight into the advantages and challenges of this system for biologics important issues to consider…

TOP